Walleye Capital LLC Biocryst Pharmaceuticals Inc Put Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$6.41 - $8.69 $19,871 - $26,939	3,100 New	3,100 $23,000
Q1 2024 May 15, 2024	BUY	$4.89 - $7.65 $34,230 - $53,550	7,000 New	7,000 $35,000
Q2 2023 Aug 14, 2023	SELL	$6.96 - $8.81 $90,480 - $114,530	-13,000 Reduced 71.04%	5,300 $37,000
Q1 2023 May 15, 2023	SELL	$7.94 - $11.84 $167,534 - $249,824	-21,100 Reduced 53.55%	18,300 $152,000
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $16,800 - $22,720	1,600 Added 4.23%	39,400 $452,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $407,861 - $559,818	37,800 New	37,800 $476,000

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.45B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.